Group 1B phospholipase A2-mediated lysophospholipid absorption directly contributes to postprandial hyperglycemia

Diabetes

Volumn 55, Issue 4, 2006, Pages 935-941

  Labonté, Eric D ^a   Kirby, R J ^a   Schildmeyer, Nicholas M ^a   Cannon, April M ^a   Huggins, Kevin W ^a   Hui, David Y ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

G6Pase, glucose 6 phosphatase; JNK, c Jun NH2 terminal kinase; LPC, lysophosphatidylcholine; PKC , protein kinase C ; Pla2g1b, group 1B phospholipase A2

Indexed keywords

GLUCOKINASE; GLUCOSE; GLUCOSE 6 PHOSPHATASE; INSULIN; LYSOPHOSPHOLIPID; PHOSPHOLIPASE A2; PHOSPHOLIPASE A2 1B; UNCLASSIFIED DRUG; PHOSPHOLIPASE A; PRIMER DNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; GENE INACTIVATION; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; GLUCOSE TOLERANCE; GLUCOSE TRANSPORT; GLYCOGEN SYNTHESIS; HEPATOMA CELL; HYPERGLYCEMIA; INSULIN RESISTANCE; LIPID ABSORPTION; LIPID BLOOD LEVEL; LIPID HYDROLYSIS; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; POSTPRANDIAL STATE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; ANIMAL; BLOOD; C57BL MOUSE; GENETICS; GLUCOSE TOLERANCE TEST; HUMAN; INTESTINE ABSORPTION; LIVER; METABOLISM; MOUSE MUTANT; NUCLEOTIDE SEQUENCE; PHYSIOLOGY;

ANIMALS; BASE SEQUENCE; DNA PRIMERS; GLUCOSE TOLERANCE TEST; HUMANS; HYPERGLYCEMIA; INTESTINAL ABSORPTION; LIVER; LYSOPHOSPHOLIPIDS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PHOSPHOLIPASES A; POSTPRANDIAL PERIOD;

EID: 33745309628     PISSN: 00121797     EISSN: 00121797     Source Type: Journal    
DOI: 10.2337/diabetes.55.04.06.db05-1286     Document Type: Article

References (28)

1. 2-deficient mice. Am J Physiol 283:E994-E1001, 2002
2. 2. J Biol Chem 269:13057-13060, 1994[Free Full Text]
3. 2. J Mol Biol 168:163-179, 1983
4. Carey MC, Small DM, Bliss CM: Lipid digestion and absorption. Annu Rev Physiol 45:651-677, 1983
5. 2 deficient mice. Gastroenterology 120:1193-1202, 2001
6. Kishimoto T, Soda Y, Matsuyama Y, Mizuno K: An enzymatic assay for lysophosphatidylcholine concentration in human serum and plasma. Clin Biochem 35:411-416, 2002
7. Singhal P, Caumo A, Carey PE, Cobelli C, Taylor R: Regulation of endogenous glucose production after a mixed meal in type 2 diabetes. Am J Physiol 283:E275-E283, 2002
8. Staehr P, Hother-Nielsen O, Beck-Nielsen H: The role of the liver in type 2 diabetes. Rev Endo Metab Disord 5:105-110, 2004
9. Beil FU, Grundy SM: Studies on plasma lipoproteins during absorption of exogenous lecithin in man. J Lipid Res 21:525-536, 1980[Abstract]
10. Homan R, Hamelehle KL: Phospholipase A2 relieves phosphatidylcholine inhibition of micellar cholesterol absorption and transport by human intestinal cell line Caco-2. J Lipid Res 39:1197-1209, 1998[Abstract/Free Full Text]
11. 2-facilitated cholesterol uptake into intestinal Caco-2 cells. J Biol Chem 272:13380-13389, 1997[Abstract/Free Full Text]
12. Rampone AJ, Machida CM: Mode of action of lecithin in suppressing cholesterol absorption. J Lipid Res 22:744-752, 1981[Abstract]
13. Young SC, Hui DY: Pancreatic lipase-colipase mediated triglyceride hydrolysis is required for cholesterol transport from lipid emulsions to intestinal cells. Biochem J 339:615-620, 1999
14. Ikeda I, Imaizumi K, Sugano M: Absorption and transport of base moieties of phosphatidylcholine and phosphatidylethanolamine in rats. Biochim Biophys Acta 921:245-253, 1987
15. Pind S, Kuksis A: Further characterization of a novel phospholipase B (phospholipase A2-lysophospholipase) from intestinal brush-border membranes. Biochem Cell Biol 69:346-357, 1991
16. Tojo H, Ichida T, Okamoto M: Purification and characterization of a catalytic domain of rat intestinal phospholipase B/lipase associated with brush border membranes. J Biol Chem 273:2214-2221, 1998[Abstract/Free Full Text]
17. Melchior DL, Carruthers A, Makriyannis A, Duclos RI, Abdel-Mageed OH: Alterations in red blood cell sugar transport by nanomolar concentrations of alkyl lysophospholipid. Biochim Biophys Acta 1028:1-8, 1990
18. Naderi S, Carruthers A, Melchior DL: Modulation of red blood cell sugar transport by lyso-lipid. Biochim Biophys Acta 985:173-181, 1998
19. Hirosumi J, Tuncman G, Chang L, Gorgun CZ, Uysal KT, Maeda K, Karin M, Hotamisligil GS: A central role for JNK in obesity and insulin resistance. Nature 420:333-336, 2002
20. Fang X, Gibson S, Flowers M, Furui T, Best RCJ, Mills GB: Lysophosphatidylcholine stimulates activator protein 1 and the c-Jun N-terminal kinase activity. J Biol Chem 272:13683-13689, 1997[Abstract/Free Full Text]
21. Lee YH, Giraud J, Davis RJ, White MF: c-Jun N-terminal kinase (JNK) mediates feedback inhibition of the insulin signaling cascade. J Biol Chem 278:2896-2902, 2003[Abstract/Free Full Text]
22. Motley ED, Kabir SM, Gardner CD, Eguchi K, Frank GD, Kuroki T, Ohba M, Yamakawa T, Eguchi S: Lysophosphatidylcholine inhibits insulin-induced akt activation through protein kinase C-alpha in vascular muscle cells. Hypertension 39:508-512, 2002[Abstract/Free Full Text]
23. Thors B, Hallorsson H, Clarke GD, Thorgeirsson G: Inhibition of Akt phosphorylation by thrombin, histamine and lysophosphatidylcholine in endothelial cells: differential role of protein kinase C. Atherosclerosis 168:245-253, 2003
24. Leitges M, Plomann M, Standaert ML, Bandyopadhyay G, Sajan MP, Kanoh Y, Farese RV: Knockout of PKC alpha enhances insulin signaling through PI3K. Mol Endocrinol 16:847-858, 2002[Abstract/Free Full Text]
25. Standaert ML, Bandyopadhyay G, Galloway L, Soto J, Ono Y, Kikkawa U, Farese RV: Effects of knockout of the PKB-beta gene on glucose transport and glucose homeostasis. Endocrinology 140:4470-4477, 1999[Abstract/Free Full Text]
26. Farese RV: Insulin-sensitive phospholipid signaling systems and glucose transport. Update II. Exp Biol Med 226:283-295, 2001[Abstract/Free Full Text]
27. Bleich D, Polak M, Chen S, Swiderek KM, Levy-Marchal C: Sera from children with type 1 diabetes mellitus react against a new group of antigens composed of lysophospholipids. Hormone Res 52:86-94, 1999
28. +-ATPase activity and plasma lysophosphatidylcholine concentrations in diabetic patients. Diabetes 43:915-919, 1994[Abstract]